Real-World Safety and Effectiveness of Controlled-Release Cilostazol in Patients with Symptomatic Peripheral Artery Disease.

Published in: Clinical drug investigation (2023)

This study demonstrated the tolerability and effectiveness of cilostazol CR treatment in patients with symptomatic PAD.

Keyphrases